$GILD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GILEAD SCIENCES INC. Get notifications about new insider transactions in GILEAD SCIENCES INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 16 2021 | GILD | GILEAD SCIENCES IN ... | Rodriguez Javier | Director | Option Exercise | M | 0.00 | 1,838 | 0 | 2,223 | |
Jun 16 2021 | GILD | GILEAD SCIENCES IN ... | Rodriguez Javier | Director | Buy | M | 0.00 | 1,838 | 0 | 1,838 | 0 to 1.8 K |
May 14 2021 | GILD | GILEAD SCIENCES IN ... | BARTON JACQUELINE K | Director | Option Exercise | A | 67.45 | 14,665 | 989,154 | 14,665 | |
May 14 2021 | GILD | GILEAD SCIENCES IN ... | BARTON JACQUELINE K | Director | Option Exercise | A | 0.00 | 2,223 | 0 | 6,776 | |
May 14 2021 | GILD | GILEAD SCIENCES IN ... | Bluestone Jeffrey | Director | Option Exercise | A | 67.45 | 14,665 | 989,154 | 14,665 | |
May 14 2021 | GILD | GILEAD SCIENCES IN ... | Bluestone Jeffrey | Director | Option Exercise | A | 0.00 | 2,223 | 0 | 3,264 | |
May 14 2021 | GILD | GILEAD SCIENCES IN ... | Rodriguez Javier | Director | Option Exercise | A | 67.45 | 14,665 | 989,154 | 14,665 | |
May 14 2021 | GILD | GILEAD SCIENCES IN ... | Rodriguez Javier | Director | Option Exercise | A | 0.00 | 2,223 | 0 | 4,061 | |
May 14 2021 | GILD | GILEAD SCIENCES IN ... | WELTERS ANTHONY | Director | Option Exercise | A | 67.45 | 14,665 | 989,154 | 14,665 | |
May 14 2021 | GILD | GILEAD SCIENCES IN ... | WELTERS ANTHONY | Director | Option Exercise | A | 0.00 | 2,223 | 0 | 3,591 | |
May 07 2021 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | M | 0.00 | 1,936 | 0 | 0 | |
May 07 2021 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Buy | M | 0.00 | 1,936 | 0 | 102,060 | 100.1 K to 102.1 K (+1.93 %) |
May 07 2021 | GILD | GILEAD SCIENCES IN ... | BARTON JACQUELINE K | Director | Option Exercise | M | 0.00 | 1,936 | 0 | 4,553 | |
May 07 2021 | GILD | GILEAD SCIENCES IN ... | BARTON JACQUELINE K | Director | Buy | M | 0.00 | 1,936 | 0 | 15,676 | 13.7 K to 15.7 K (+14.09 %) |
May 07 2021 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | M | 0.00 | 1,936 | 0 | 4,028 | |
May 07 2021 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Buy | M | 0.00 | 1,936 | 0 | 33,058 | 31.1 K to 33.1 K (+6.22 %) |
May 07 2021 | GILD | GILEAD SCIENCES IN ... | MANWANI HARISH | Director | Option Exercise | M | 0.00 | 1,936 | 0 | 0 | |
May 07 2021 | GILD | GILEAD SCIENCES IN ... | MANWANI HARISH | Director | Buy | M | 0.00 | 1,936 | 0 | 5,654 | 3.7 K to 5.7 K (+52.07 %) |
May 05 2021 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Sell | S | 66.09 | 19,496 | 1,288,547 | 8,068 | 27.6 K to 8.1 K (-70.73 %) |
May 04 2021 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | M | 20.65 | 20,282 | 418,722 | 0 | |
May 04 2021 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Sell | S | 64.57 | 20,282 | 1,309,655 | 31,122 | 51.4 K to 31.1 K (-39.46 %) |
May 04 2021 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Buy | M | 20.65 | 20,282 | 418,722 | 51,404 | 31.1 K to 51.4 K (+65.17 %) |
Mar 31 2021 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 31 | 0 | 2,883 | |
Mar 31 2021 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 63 | 0 | 5,872 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Option Exercise | A | 0.00 | 15,845 | 0 | 47,435 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Option Exercise | A | 63.91 | 92,205 | 5,892,822 | 92,205 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Option Exercise | M | 0.00 | 3,025 | 0 | 31,590 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Payment of Exercise | F | 63.91 | 1,435 | 91,711 | 27,564 | 29 K to 27.6 K (-4.95 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Buy | M | 0.00 | 3,025 | 0 | 28,999 | 26 K to 29 K (+11.65 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,794 | 0 | 42,936 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | Chief Financial Off ... | Option Exercise | A | 0.00 | 16,430 | 0 | 46,730 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | Chief Financial Off ... | Option Exercise | A | 63.91 | 95,620 | 6,111,074 | 95,620 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | Chief Financial Off ... | Payment of Exercise | F | 63.91 | 1,771 | 113,185 | 34,930 | 36.7 K to 34.9 K (-4.83 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | Chief Financial Off ... | Buy | M | 0.00 | 3,794 | 0 | 36,701 | 32.9 K to 36.7 K (+11.53 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | Chief Financial Off ... | Grant | A | 56.86 | 364 | 20,696 | 32,907 | 32.5 K to 32.9 K (+1.12 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Option Exercise | A | 0.00 | 5,085 | 0 | 18,387 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Option Exercise | A | 63.91 | 17,110 | 1,093,500 | 17,110 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Option Exercise | M | 0.00 | 2,025 | 0 | 13,302 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Payment of Exercise | F | 63.91 | 609 | 38,921 | 18,825 | 19.4 K to 18.8 K (-3.13 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Buy | M | 0.00 | 2,025 | 0 | 19,434 | 17.4 K to 19.4 K (+11.63 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Option Exercise | A | 63.91 | 96,760 | 6,183,932 | 96,760 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Option Exercise | A | 0.00 | 16,625 | 0 | 37,189 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Option Exercise | M | 0.00 | 3,455 | 0 | 20,564 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Payment of Exercise | F | 63.91 | 1,639 | 104,748 | 14,079 | 15.7 K to 14.1 K (-10.43 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Buy | M | 0.00 | 3,455 | 0 | 15,718 | 12.3 K to 15.7 K (+28.17 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Grant | A | 56.86 | 364 | 20,696 | 12,263 | 11.9 K to 12.3 K (+3.06 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | A | 63.91 | 72,855 | 4,656,163 | 72,855 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | A | 0.00 | 12,520 | 0 | 25,751 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | M | 0.00 | 2,593 | 0 | 13,231 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Sell | S | 63.36 | 1,486 | 94,153 | 29,166 | 30.7 K to 29.2 K (-4.85 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Payment of Exercise | F | 63.91 | 1,107 | 70,748 | 30,652 | 31.8 K to 30.7 K (-3.49 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Buy | M | 0.00 | 2,593 | 0 | 31,759 | 29.2 K to 31.8 K (+8.89 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Grant | A | 56.86 | 334 | 18,990 | 29,166 | 28.8 K to 29.2 K (+1.16 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Option Exercise | M | 0.00 | 10,800 | 0 | 150,856 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Option Exercise | A | 63.91 | 307,355 | 19,643,058 | 307,355 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Option Exercise | A | 0.00 | 52,810 | 0 | 161,656 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Payment of Exercise | F | 63.91 | 5,123 | 327,411 | 142,013 | 147.1 K to 142 K (-3.48 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Buy | M | 0.00 | 10,800 | 0 | 147,136 | 136.3 K to 147.1 K (+7.92 %) |
Mar 03 2021 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Option Exercise | M | 0.00 | 11,363 | 0 | 108,846 | |
Mar 03 2021 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Option Exercise | M | 0.00 | 42,923 | 0 | 120,209 | |
Mar 03 2021 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Payment of Exercise | F | 62.46 | 24,620 | 1,537,765 | 136,336 | 161 K to 136.3 K (-15.30 %) |
Mar 03 2021 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Buy | M | 0.00 | 11,363 | 0 | 160,956 | 149.6 K to 161 K (+7.60 %) |
Mar 03 2021 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Buy | M | 0.00 | 42,923 | 0 | 149,593 | 106.7 K to 149.6 K (+40.24 %) |
Feb 09 2021 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Option Exercise | M | 0.00 | 1,866 | 0 | 16,105 | |
Feb 09 2021 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Payment of Exercise | F | 68.46 | 533 | 36,489 | 16,828 | 17.4 K to 16.8 K (-3.07 %) |
Feb 09 2021 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Buy | M | 0.00 | 1,866 | 0 | 17,361 | 15.5 K to 17.4 K (+12.04 %) |
Feb 09 2021 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | M | 0.00 | 2,728 | 0 | 15,824 | |
Feb 09 2021 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Payment of Exercise | F | 68.46 | 753 | 51,550 | 30,807 | 31.6 K to 30.8 K (-2.39 %) |
Feb 09 2021 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Buy | M | 0.00 | 2,728 | 0 | 31,560 | 28.8 K to 31.6 K (+9.46 %) |
Feb 09 2021 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Option Exercise | M | 0.00 | 1,818 | 0 | 30,300 | |
Feb 09 2021 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Payment of Exercise | F | 68.46 | 538 | 36,831 | 32,543 | 33.1 K to 32.5 K (-1.63 %) |
Feb 09 2021 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Buy | M | 0.00 | 1,818 | 0 | 33,081 | 31.3 K to 33.1 K (+5.82 %) |
Feb 02 2021 | GILD | GILEAD SCIENCES IN ... | GILEAD SCIENCES INC | 10% Owner | Buy | P | 39.00 | 5,650,000 | 220,350,000 | 13,913,029 | 8.3 M to 13.9 M (+68.38 %) |
Feb 02 2021 | GILD | GILEAD SCIENCES IN ... | GILEAD SCIENCES INC | 10% Owner | Buy | P | 39.00 | 5,650,000 | 220,350,000 | 13,913,029 | 8.3 M to 13.9 M (+68.38 %) |
Jan 29 2021 | GILD | GILEAD SCIENCES IN ... | Horning Sandra | Director | Option Exercise | M | 0.00 | 632 | 0 | 1,936 | |
Jan 29 2021 | GILD | GILEAD SCIENCES IN ... | Horning Sandra | Director | Buy | M | 0.00 | 632 | 0 | 632 | 0 to 632 |
Jan 28 2021 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Payment of Exercise | F | 66.70 | 3,736 | 249,191 | 38,543 | 42.3 K to 38.5 K (-8.84 %) |
Jan 28 2021 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Grant | A | 0.00 | 13,447 | 0 | 42,279 | 28.8 K to 42.3 K (+46.64 %) |
Jan 28 2021 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Grant | A | 0.00 | 14,188 | 0 | 28,832 | 14.6 K to 28.8 K (+96.89 %) |
Jan 28 2021 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Grant | A | 0.00 | 1,294 | 0 | 15,495 | 14.2 K to 15.5 K (+9.11 %) |
Jan 28 2021 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Grant | A | 0.00 | 8,068 | 0 | 25,974 | 17.9 K to 26 K (+45.06 %) |
Jan 28 2021 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Grant | A | 0.00 | 9,214 | 0 | 11,899 | 2.7 K to 11.9 K (+343.17 %) |
Jan 28 2021 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Grant | A | 0.00 | 59,100 | 0 | 106,670 | 47.6 K to 106.7 K (+124.24 %) |
Jan 28 2021 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Payment of Exercise | F | 66.70 | 878 | 58,563 | 31,263 | 32.1 K to 31.3 K (-2.73 %) |
Jan 28 2021 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Grant | A | 0.00 | 2,941 | 0 | 32,141 | 29.2 K to 32.1 K (+10.07 %) |
Jan 28 2021 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Grant | A | 0.00 | 12,914 | 0 | 29,200 | 16.3 K to 29.2 K (+79.30 %) |
Jan 25 2021 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | M | 20.65 | 20,282 | 418,722 | 0 | |
Jan 25 2021 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Buy | M | 20.65 | 20,282 | 418,722 | 74,203 | 53.9 K to 74.2 K (+37.61 %) |
Jan 04 2021 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 69 | 0 | 5,809 | |
Jan 04 2021 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 34 | 0 | 2,852 | |
Dec 29 2020 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Gift | G | 0.00 | 21,720 | 0 | 53,921 | 75.6 K to 53.9 K (-28.71 %) |
Dec 10 2020 | GILD | GILEAD SCIENCES IN ... | Bluestone Jeffrey | Director | Option Exercise | A | 0.00 | 1,041 | 0 | 1,041 | |
Dec 10 2020 | GILD | GILEAD SCIENCES IN ... | Bluestone Jeffrey | Director | Option Exercise | A | 61.17 | 5,879 | 359,618 | 5,879 | |
Nov 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Option Exercise | M | 0.00 | 1,913 | 0 | 32,118 | |
Nov 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Option Exercise | M | 0.00 | 1,133 | 0 | 34,031 | |
Nov 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Payment of Exercise | F | 60.62 | 1,399 | 84,807 | 16,286 | 17.7 K to 16.3 K (-7.91 %) |
Nov 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Buy | M | 0.00 | 1,913 | 0 | 17,685 | 15.8 K to 17.7 K (+12.13 %) |
Nov 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Buy | M | 0.00 | 1,133 | 0 | 15,772 | 14.6 K to 15.8 K (+7.74 %) |
Nov 12 2020 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Option Exercise | M | 0.00 | 5,101 | 0 | 24,019 | |
Nov 12 2020 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Payment of Exercise | F | 60.62 | 2,416 | 146,458 | 2,685 | 5.1 K to 2.7 K (-47.36 %) |
Nov 12 2020 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Buy | M | 0.00 | 5,101 | 0 | 5,101 | 0 to 5.1 K |
Nov 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Option Exercise | M | 0.00 | 657 | 0 | 17,971 | |
Nov 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Option Exercise | M | 0.00 | 773 | 0 | 18,628 | |
Nov 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Payment of Exercise | F | 60.62 | 611 | 37,039 | 14,201 | 14.8 K to 14.2 K (-4.13 %) |
Nov 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Buy | M | 0.00 | 657 | 0 | 14,812 | 14.2 K to 14.8 K (+4.64 %) |
Nov 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Buy | M | 0.00 | 773 | 0 | 14,155 | 13.4 K to 14.2 K (+5.78 %) |
Nov 05 2020 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Payment of Exercise | F | 58.83 | 12,282 | 722,550 | 17,906 | 30.2 K to 17.9 K (-40.69 %) |
Nov 05 2020 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Grant | A | 0.00 | 26,270 | 0 | 30,188 | 3.9 K to 30.2 K (+670.50 %) |
Oct 26 2020 | GILD | GILEAD SCIENCES IN ... | WELTERS ANTHONY | Director | Option Exercise | A | 60.67 | 7,718 | 468,251 | 7,718 | |
Oct 26 2020 | GILD | GILEAD SCIENCES IN ... | WELTERS ANTHONY | Director | Option Exercise | A | 0.00 | 1,368 | 0 | 1,368 | |
Oct 01 2020 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 31 | 0 | 2,818 | |
Aug 19 2020 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Sell | S | 68.32 | 182 | 12,434 | 0 | 182 to 0 (-100.00 %) |
Aug 19 2020 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Grant | A | 57.43 | 182 | 10,452 | 182 | 0 to 182 |
Aug 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Option Exercise | M | 0.00 | 2,306 | 0 | 35,164 | |
Aug 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Payment of Exercise | F | 68.51 | 1,022 | 70,017 | 14,639 | 15.7 K to 14.6 K (-6.53 %) |
Aug 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Buy | M | 0.00 | 2,306 | 0 | 15,661 | 13.4 K to 15.7 K (+17.27 %) |
Aug 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Option Exercise | M | 0.00 | 3,345 | 0 | 19,401 | |
Aug 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Payment of Exercise | F | 68.51 | 1,384 | 94,818 | 13,382 | 14.8 K to 13.4 K (-9.37 %) |
Aug 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Buy | M | 0.00 | 3,345 | 0 | 14,766 | 11.4 K to 14.8 K (+29.29 %) |
Jul 28 2020 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Option Exercise | M | 0.00 | 7,505 | 0 | 34,615 | |
Jul 28 2020 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Payment of Exercise | F | 73.64 | 3,587 | 264,147 | 3,918 | 7.5 K to 3.9 K (-47.79 %) |
Jul 28 2020 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Buy | M | 0.00 | 7,505 | 0 | 7,505 | 0 to 7.5 K |
Jul 01 2020 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 64 | 0 | 7,097 | |
Jul 01 2020 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 25 | 0 | 2,788 | |
Jun 25 2020 | GILD | GILEAD SCIENCES IN ... | Rodriguez Javier | Director | Sell | S | 75.50 | 189 | 14,270 | 0 | 189 to 0 (-100.00 %) |
Jun 16 2020 | GILD | GILEAD SCIENCES IN ... | Rodriguez Javier | Director | Option Exercise | A | 0.00 | 1,838 | 0 | 1,838 | |
Jun 16 2020 | GILD | GILEAD SCIENCES IN ... | Rodriguez Javier | Director | Option Exercise | A | 73.97 | 8,667 | 641,098 | 8,667 | |
Jun 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Option Exercise | M | 0.00 | 3,646 | 0 | 37,470 | |
Jun 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Payment of Exercise | F | 77.07 | 1,691 | 130,325 | 13,355 | 15 K to 13.4 K (-11.24 %) |
Jun 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Buy | M | 0.00 | 3,646 | 0 | 15,046 | 11.4 K to 15 K (+31.98 %) |
May 20 2020 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Sell | J | 0.00 | 13,208 | 0 | 75,641 | 88.8 K to 75.6 K (-14.87 %) |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | MANWANI HARISH | Director | Option Exercise | A | 77.47 | 7,886 | 610,928 | 7,886 | |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | MANWANI HARISH | Director | Option Exercise | A | 0.00 | 1,936 | 0 | 1,936 | |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | MANWANI HARISH | Director | Option Exercise | M | 0.00 | 2,270 | 0 | 0 | |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | MANWANI HARISH | Director | Payment of Exercise | F | 79.14 | 419 | 33,160 | 3,718 | 4.1 K to 3.7 K (-10.13 %) |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | MANWANI HARISH | Director | Buy | M | 0.00 | 2,270 | 0 | 4,137 | 1.9 K to 4.1 K (+121.59 %) |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 77.47 | 7,886 | 610,928 | 7,886 | |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 1,936 | 0 | 5,964 | |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | M | 0.00 | 2,270 | 0 | 4,028 | |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Buy | M | 0.00 | 2,270 | 0 | 29,688 | 27.4 K to 29.7 K (+8.28 %) |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | A | 77.47 | 7,886 | 610,928 | 7,886 | |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | A | 0.00 | 1,936 | 0 | 1,936 | |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | M | 0.00 | 2,270 | 0 | 0 | |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Buy | M | 0.00 | 2,270 | 0 | 100,124 | 97.9 K to 100.1 K (+2.32 %) |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 77.47 | 7,886 | 610,928 | 7,886 | |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 1,936 | 0 | 9,830 | |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | M | 0.00 | 2,270 | 0 | 7,894 | |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Buy | M | 0.00 | 2,270 | 0 | 88,849 | 86.6 K to 88.8 K (+2.62 %) |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | BARTON JACQUELINE K | Director | Option Exercise | A | 77.47 | 7,886 | 610,928 | 7,886 | |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | BARTON JACQUELINE K | Director | Option Exercise | A | 0.00 | 1,936 | 0 | 6,489 |